Copyright Reports & Markets. All rights reserved.

Global Metastatic Melanoma Diagnostic Market Status and Forecast 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Metastatic Melanoma Diagnostic Market Status and Forecast (2016-2027)
      • 1.3.2 Global Metastatic Melanoma Diagnostic Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Metastatic Melanoma Diagnostic Supply by Company

    • 2.1 Global Metastatic Melanoma Diagnostic Sales Value by Company
    • 2.2 Metastatic Melanoma Diagnostic Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Metastatic Melanoma Diagnostic Market Status by Type

    • 3.1 Metastatic Melanoma Diagnostic Type Introduction
      • 3.1.1 BRAF Mutation
      • 3.1.2 Circulating Tumor Cells (CTCs)
      • 3.1.3 Immunohistochemistry
      • 3.1.4 Others
    • 3.2 Global Metastatic Melanoma Diagnostic Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Metastatic Melanoma Diagnostic Market Status by Application

    • 4.1 Metastatic Melanoma Diagnostic Segment by Application
      • 4.1.1 Pathology Laboratories
      • 4.1.2 Hospitals
      • 4.1.3 Cancer Research Centres
      • 4.1.4 Others
    • 4.2 Global Metastatic Melanoma Diagnostic Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Metastatic Melanoma Diagnostic Market Status by Region

    • 5.1 Global Metastatic Melanoma Diagnostic Market by Region
    • 5.2 North America Metastatic Melanoma Diagnostic Market Status
    • 5.3 Europe Metastatic Melanoma Diagnostic Market Status
    • 5.4 Asia Pacific Metastatic Melanoma Diagnostic Market Status
    • 5.5 Central & South America Metastatic Melanoma Diagnostic Market Status
    • 5.6 Middle East & Africa Metastatic Melanoma Diagnostic Market Status

    6 North America Metastatic Melanoma Diagnostic Market Status

    • 6.1 North America Metastatic Melanoma Diagnostic Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Metastatic Melanoma Diagnostic Market Status

    • 7.1 Europe Metastatic Melanoma Diagnostic Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Metastatic Melanoma Diagnostic Market Status

    • 8.1 Asia Pacific Metastatic Melanoma Diagnostic Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Metastatic Melanoma Diagnostic Market Status

    • 9.1 Central & South America Metastatic Melanoma Diagnostic Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Metastatic Melanoma Diagnostic Market Status

    • 10.1 Middle East & Africa Metastatic Melanoma Diagnostic Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Metastatic Melanoma Diagnostic Market Forecast by Type and by Application

    • 12.1 Global Metastatic Melanoma Diagnostic Sales Value Forecast (2022-2027)
    • 12.2 Global Metastatic Melanoma Diagnostic Forecast by Type
    • 12.3 Global Metastatic Melanoma Diagnostic Forecast by Application

    13 Global Metastatic Melanoma Diagnostic Market Forecast by Region/Country

    • 13.1 Global Metastatic Melanoma Diagnostic Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Sysmex Inostics
      • 14.1.1 Company Information
      • 14.1.2 Metastatic Melanoma Diagnostic Product Introduction
      • 14.1.3 Sysmex Inostics Metastatic Melanoma Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Pathway Genomics Corporation
      • 14.2.1 Company Information
      • 14.2.2 Metastatic Melanoma Diagnostic Product Introduction
      • 14.2.3 Pathway Genomics Corporation Metastatic Melanoma Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 NeoGenomics
      • 14.3.1 Company Information
      • 14.3.2 Metastatic Melanoma Diagnostic Product Introduction
      • 14.3.3 NeoGenomics Metastatic Melanoma Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Myriad Genetics
      • 14.4.1 Company Information
      • 14.4.2 Metastatic Melanoma Diagnostic Product Introduction
      • 14.4.3 Myriad Genetics Metastatic Melanoma Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Foundation Medicine
      • 14.5.1 Company Information
      • 14.5.2 Metastatic Melanoma Diagnostic Product Introduction
      • 14.5.3 Foundation Medicine Metastatic Melanoma Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Dermtech
      • 14.6.1 Company Information
      • 14.6.2 Metastatic Melanoma Diagnostic Product Introduction
      • 14.6.3 Dermtech Metastatic Melanoma Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Castle Biosciences
      • 14.7.1 Company Information
      • 14.7.2 Metastatic Melanoma Diagnostic Product Introduction
      • 14.7.3 Castle Biosciences Metastatic Melanoma Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Cancer Genetics
      • 14.8.1 Company Information
      • 14.8.2 Metastatic Melanoma Diagnostic Product Introduction
      • 14.8.3 Cancer Genetics Metastatic Melanoma Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Abbott Laboratories
      • 14.9.1 Company Information
      • 14.9.2 Metastatic Melanoma Diagnostic Product Introduction
      • 14.9.3 Abbott Laboratories Metastatic Melanoma Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Metastatic Melanoma Diagnostic market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Metastatic Melanoma Diagnostic industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Metastatic Melanoma Diagnostic market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Metastatic Melanoma Diagnostic Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Melanoma Diagnostic market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Metastatic Melanoma Diagnostic Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Metastatic Melanoma Diagnostic industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      BRAF Mutation
      Circulating Tumor Cells (CTCs)
      Immunohistochemistry
      Others

      Segmented by Application
      Pathology Laboratories
      Hospitals
      Cancer Research Centres
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Sysmex Inostics
      Pathway Genomics Corporation
      NeoGenomics
      Myriad Genetics
      Foundation Medicine
      Dermtech
      Castle Biosciences
      Cancer Genetics
      Abbott Laboratories
      Buy now